fluorodeoxyglucose f18 has been researched along with Adenocarcinoma, Endometrioid in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, YL; Peng, NJ; Wang, JS | 1 |
| Cho, YL; Chong, GO; Hong, DG; Jeong, SY; Lee, DW; Lee, YH; Lee, YS; Park, JY | 1 |
| Arvas, M; Aydin, O; Bese, T; Demirayak, G; Demirkiran, F; Hallac, M; Ilvan, S; Kahramanoglu, I; Sal, V; Tokgozoglu, N; Turan, H; Vatankulu, B | 1 |
| İbiş, E; Kahraman, A; Konuralp Atakul, B; Koyuncu, K; Ortac, F; Soydal, Ç; Sükür, YE; Taşkın, S | 1 |
| Aksu, G; Altun, E; Bilici, A; Karci, E; Ozkara, SK; Ustaalioglu, BB; Uygun, K | 1 |
| Hiramatsu, Y; Hongo, A; Kanazawa, S; Kodama, J; Nakamura, K; Okumura, Y | 1 |
| Hiramatsu, Y; Hongo, A; Kodama, J; Nakamura, K | 1 |
| Fujibayashi, Y; Kawahara, K; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsuchida, T; Yonekura, Y; Yoshida, Y | 1 |
| Abdul-Karim, FW; Faulhaber, P; Miraldi, F; Rose, PG | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer.
Topics: Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reference Standards; Tumor Burden | 2010 |
8 other study(ies) available for fluorodeoxyglucose f18 and Adenocarcinoma, Endometrioid
| Article | Year |
|---|---|
Endometrioid Intraepithelial Neoplasia: An Endometrial Precancer Detected by 18F-FDG PET/CT.
Topics: Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Uterine Cervical Dysplasia | 2018 |
Role of SUVmax and GLUT-1 Expression in Determining Tumor Aggressiveness in Patients With Clinical Stage I Endometrioid Endometrial Cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose Transporter Type 1; Humans; Hysterectomy; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tissue Distribution; Tomography, X-Ray Computed | 2015 |
The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Preoperative Care; Retrospective Studies; Sentinel Lymph Node | 2016 |
Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Topics: Adult; Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Myometrium; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Preoperative Period; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity | 2017 |
An unusual case of recurrent endometrial cancer presented with isolated cervical lymph node metastasis.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Combined Modality Therapy; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography | 2009 |
The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; CA-125 Antigen; Carcinoma, Endometrioid; Disease-Free Survival; Endometrial Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Membrane Proteins; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed | 2011 |
Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.
Topics: Adenocarcinoma, Mucinous; Biomarkers, Tumor; Carcinoma, Endometrioid; Cell Division; Cystadenocarcinoma, Serous; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Ki-67 Antigen; Monosaccharide Transport Proteins; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2004 |
Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy.
Topics: Adenocarcinoma, Mucinous; Adenofibroma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Endometrioid; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Peritoneal Neoplasms; Radiopharmaceuticals; Reoperation; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |